The Impact of the New EU Clinical Trial Regulation 536/2014 on CMC Activities

After many years of anticipation, the new Clinical Trial Regulation (CTR 536/2014) supplemented by (EU)2017/1569 which defines GMP requirements for Investigational Medicinal Products (IMPs) was finally implemented on 31 January 2022. This new CTR will replace the European Directive 2001/20/EC. The transition period where studies can be submitted under the directive or the regulation will end on 31 January 2023.

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.